27th Feb 2015 10:03
LONDON (Alliance News) - Clinigen Group PLC said Friday it has signed a deal with Merck Sharp & Dohme Ltd to distribute its human health products for use in trials carried out in Europe.
Under the deal, Clinigen will be a preferred distributor of Merck Sharp & Dohme's products and will manage enquiries, order receipts and distribution.
No financial details of the agreement were disclosed.
Shares in Clinigen are trading down 0.5% at 537.50 pence Friday morning.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
CLIN.L